Abstract
Rheumatoid arthritis (RA), a prototypical immune-mediated inflammatory disease, is characterized by increased cardiovascular morbidity and mortality, independent from the established cardiovascular risk factors. The chronic inflammatory state, a hallmark of RA, is considered to be a driving force for accelerated atherogenesis. Concurrent conditions that expedite the atherosclerotic process in RA involve endothelial dysfunction, dyslipidemia and procoagulant changes. These facilitating states can be reversed by retraction of the systemic inflammatory activity. Consequently, aggressive control of disease activity has been suggested to be instrumental for cardiovascular risk reduction. In the present review, we focus on these critical determinant that promote premature atherosclerosis in RA.
Keywords: Atheroslerosis, rheumatoid arthritis, cardiovascular risk factors, chronic inflammation, human cancers, pathogenesis, skin carcinogenesis, hydroxytyrosol, tyrosol, Hydroxytyrosol (3,4 DHPEA-EDA), HL60 (human promyelocytic leukemia cells), caspases, poly-ADP-ribose polym-erase, cytochrome, cytosolic proteins, Her-2/neu, Her2/neu on-cogene, cellular proliferation, transformation, differentiation, mo-tility, metastasis, p185 Her-2/neu oncoprotein, BT-474, SK-Br3 cells, trastuzumab (Her-ceptinTM), Akt, PI-3 kinase/Akt pathway, erythrodiol, pentacyclic triterpenic acids, Olea Euopaea, HT-29 cells, reactive oxygen species, Confocal micros-copy analysis, squalene, cholesterol biosynthesis, Ras farnesylation, MAPK pathway, Bcl-2 pathways, Apaf 1, apoptosome, necrotic cells, Caiazzana and Ravece, colorectal can-cer cell lines, ATM-p53, pinoresinol, oleocanthal, Bcl-2 family, Bax, trol of the G2/M checkpoint, p53 is directly controlled by the ATM-ATR genes
Current Pharmaceutical Design
Title: Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis
Volume: 17 Issue: 1
Author(s): R. J. Bisoendial, E. S.G. Stroes and P. P. Tak
Affiliation:
Keywords: Atheroslerosis, rheumatoid arthritis, cardiovascular risk factors, chronic inflammation, human cancers, pathogenesis, skin carcinogenesis, hydroxytyrosol, tyrosol, Hydroxytyrosol (3,4 DHPEA-EDA), HL60 (human promyelocytic leukemia cells), caspases, poly-ADP-ribose polym-erase, cytochrome, cytosolic proteins, Her-2/neu, Her2/neu on-cogene, cellular proliferation, transformation, differentiation, mo-tility, metastasis, p185 Her-2/neu oncoprotein, BT-474, SK-Br3 cells, trastuzumab (Her-ceptinTM), Akt, PI-3 kinase/Akt pathway, erythrodiol, pentacyclic triterpenic acids, Olea Euopaea, HT-29 cells, reactive oxygen species, Confocal micros-copy analysis, squalene, cholesterol biosynthesis, Ras farnesylation, MAPK pathway, Bcl-2 pathways, Apaf 1, apoptosome, necrotic cells, Caiazzana and Ravece, colorectal can-cer cell lines, ATM-p53, pinoresinol, oleocanthal, Bcl-2 family, Bax, trol of the G2/M checkpoint, p53 is directly controlled by the ATM-ATR genes
Abstract: Rheumatoid arthritis (RA), a prototypical immune-mediated inflammatory disease, is characterized by increased cardiovascular morbidity and mortality, independent from the established cardiovascular risk factors. The chronic inflammatory state, a hallmark of RA, is considered to be a driving force for accelerated atherogenesis. Concurrent conditions that expedite the atherosclerotic process in RA involve endothelial dysfunction, dyslipidemia and procoagulant changes. These facilitating states can be reversed by retraction of the systemic inflammatory activity. Consequently, aggressive control of disease activity has been suggested to be instrumental for cardiovascular risk reduction. In the present review, we focus on these critical determinant that promote premature atherosclerosis in RA.
Export Options
About this article
Cite this article as:
J. Bisoendial R., S.G. Stroes E. and P. Tak P., Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis, Current Pharmaceutical Design 2011; 17 (1) . https://dx.doi.org/10.2174/138161211795049741
DOI https://dx.doi.org/10.2174/138161211795049741 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neem Gum Based Solid Dispersion in Development of Aceclofenac Tablet with Enhanced Bioavailability
Drug Delivery Letters Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Feasibility and Prospects for Anti-Inflammatory Antibodies in the Treatment and Disease Management of Influenza
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Methotrexate Induced Pneumonitis: A Review Article
Current Respiratory Medicine Reviews Progress in Multiple Sclerosis Genetics
Current Genomics Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Effects of the Novel Non-Peptidyl Low Molecular Weight Radical Scavenger IAC in Different Models of Inflammation: A New Perspective in Anti-Inflammatory Therapy
Current Medicinal Chemistry Innovations in siRNA Research: A Technology Comes of Age
Recent Patents on Anti-Infective Drug Discovery Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
Current Pharmaceutical Design Indolinones as Promising Scaffold as Kinase Inhibitors: A Review
Mini-Reviews in Medicinal Chemistry IgG Dimers in Multidonor-Derived Immunoglobulins: Aspects of Generation and Function
Current Pharmaceutical Design Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study
Drug Metabolism Letters Metalloproteinases: potential therapeutic targets for rheumatoid arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiovascular disease management through restrained inflammatory responses
Current Pharmaceutical Design Humanized SCID Mice Models of SLE
Current Pharmaceutical Design Biotherapy for Autoimmune Liver Diseases
Current Pharmaceutical Biotechnology Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Screening Methods for Antioxidants-A Review
Mini-Reviews in Medicinal Chemistry Bone Diseases Associated with Human Immunodeficiency Virus Infection: Pathogenesis, Risk Factors and Clinical Management
Current Molecular Medicine